Stocks and Investing
Stocks and Investing
Wed, January 20, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BGNE) at Buy with Increased Target to $375 on, Jan 19th, 2021
Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $310 to $375 on, Jan 19th, 2021.
Matthew has made no other calls on BGNE in the last 4 months.
There are 3 other peers that have a rating on BGNE. Out of the 3 peers that are also analyzing BGNE, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Wangzhi Li of "Ladenburg Thalmann" Upgraded from Hold to Strong Buy and Held Target at $278 on, Tuesday, December 8th, 2020
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $327 on, Thursday, November 19th, 2020
- Tyler Van Buren of "Piper Sandler" Downgraded from Hold to Sell and Held Target at $185 on, Friday, November 6th, 2020
Contributing Sources